Find out what we're talking about
Posted on 10.23.20
Impressions from the world’s first conference on Coronavirus- ECCVID 2020
This was my first experience with attending a virtual conference. I was really curious about how it would be arranged, and how the experience would translate to a virtual audience.Navigating the ECCVID 2020 platform was very simple. Afte...
Posted on 08.12.20
Use of Cyclosporin A as a potential for coronavirus inhibition for COVID-19 disease
The strategy of repurposing existing compounds to combat the new Coronavirus (SARS-Cov2) that causes COVID-19 is one that is being pursued on a global level. As SARS-CoV-2 is quite similar to SARS-CoV based on the full-length genome pro...
Posted on 05.21.20
TOKU-E Talks: Something old, something new: Repurposing compounds against COVID-19
The coronavirus disease 2019 (COVID-19) has spread rapidly into a global pandemic and research is underway to discover compounds that have activity against SARS-CoV2, that belongs to the β genus of Coronaviruses (α and β infect mammals w...
Posted on 05.11.20
TOKU-E Talks: In life science news
On a cold day in January, we hosted a reporter from the Bellingham Business Journal at a snowy construction site. But this was not just any old site: This is where our new TOKU-E facility is being built (pictured), which will be twice...
Posted on 04.13.20
TOKU-E Talks: Breaking Ground
Our new home is on the horizon, and we are excited. The 15,750 square foot facility is expected to be completed in August, 2020 and is located at 4112 Bakerview Spur, in the Irongate business park, Bellingham, WA. The facility will hav...